Efficacy Demonstrated Both In Registries and a Randomized Controlled Trial
Confidence In Clinical Outcomes
- Nearly 600 patients followed to 5 years1
- More than 3400 patients studied2
1ENDEAVOR II, Driver control arm.
2More than 3400 patients studied includes:E II Driver arm (n=599), Driver registry (n=298), International Driver Registry (n=792), DRASTIC (n=805), DRASTIC II (n=600), Micro Driver registry (n = 135), CLASS study (n=202) .
Low TLR In Registries
Comprehensive Experience In Real-World Patients
CLASS study 6-mo TLR. Driver Registry 9-mo TLR; International Driver Registry 9-mo TLR.
Durable Efficacy to 5 Years In Pivotal Trial
- 16.3% at 5 years, an increase of just over three percent from 13.1% four years earlier
Years 1–5 TLR E II 5-year, Driver control arm.
||TVF at 9 mo
|Lesion length (mm)
|Pre-procedure MLD (mm)